The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
Open accessAbstract
Background Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with reductions in both the concentration of LDL cholesterol and the risk of coronary heart disease, but also with modest hyperglycaemia, increased bodyweight, and modestly increased risk of type 2 diabetes, which in no way offsets their substantial benefits. We sought to investigate the associations of LDL cholesterol-lowering PCSK9 variants with type 2 diabetes and related biomarkers to gauge the likely effects of PCSK9 inhibitors on diabetes risk. Methods In this mendelian randomisation study, we used data from cohort studies, randomised controlled trials, case control studies, and genetic consortia to estimate associations of PCSK9 genetic variants with LDL cholesterol, fasting blood glucose, HbA 1c , fasting insulin, bodyweight, waist-to-hip ratio, BMI, and risk of type 2 diabetes, using a standardised analysis plan, meta-analyses, and weighted gene-centric scores. Findings Data were available for more than 550 000 individuals and 51 623 cases of type 2 diabetes. Combined analyses of four independent PCSK9 variants (rs11583680, rs11591147, rs2479409, and rs11206510) scaled to 1 mmol/L lower LDL cholesterol showed associations with increased fasting glucose (0·09 mmol/L, 95% CI 0·02 to 0·15), bodyweight (1·03 kg, 0·24 to 1·82), waist-to-hip ratio (0·006, 0·003 to 0·010), and an odds ratio for type diabetes of 1·29 (1·11 to 1·50). Based on the collected data, we did not identify associations with HbA 1c (0·03%, −0·01 to 0·08), fasting insulin (0·00%, −0·06 to 0·07), and BMI (0·11 kg/m 2 , −0·09 to 0·30). Interpretation PCSK9 variants associated with lower LDL cholesterol were also associated with circulating higher fasting glucose concentration, bodyweight, and waist-to-hip ratio, and an increased risk of type 2 diabetes. In trials of PCSK9 inhibitor drugs, investigators should carefully assess these safety outcomes and quantify the risks and benefits of PCSK9 inhibitor treatment, as was previously done for statins. Funding British Heart Foundation, and University College London Hospitals NHS Foundation Trust (UCLH) National Institute for Health Research (NIHR) Biomedical Research Centre.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mendelian randomisation studies 8,[19][20][21] of genetic polymorphisms that mimic the effects of statins, ezetimibe, or PCSK9 inhibitors suggest that lifelong reductions in LDL cholesterol, irrespective of the mechanism, are associated with an increased risk of diabetes.”
From Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial (2019) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, we found no significant association between PCSK9 inhibition and diabetes (RR 1.04; 95% CI 0.77 to 1.41; I2 = 0%), despite the weak signal reported in some Mendelian randomization studies[30,31], with the discordance most likely arising from the fact that genetic studies reflect lifetime exposure as compared to short-term pharmacological interventions.”
From Oral PCSK9 inhibitors for elevated LDL-C: A systematic review and meta-analysis of randomized trials (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mendelian randomisation analyses 8,20,21 have shown that genetically determined loss of function of PCSK9 is associated with an increased risk of incident diabetes, but clinical trials of PCSK9 inhibitors have shown no such effect.9”
The cited source says what the claim attributes to it.
In the citing paper
“We created a genetic risk score (GRS) for PCSK9 function using four single nucleotide polymorphisms (SNPs) at or near the PCSK9 locus that have been previously demonstrated in a genetic risk score to strongly associate with lower LDL-C in individuals of European genetic ancestry [4]: rs11583680, rs11591147, rs2479409, and rs11206510.”
From PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“Further, our study had less power to detect a difference in T2D risk when compared to other larger published meta-analyses [4].”
From PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort (2020) · cites this paper as [4]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
A general framework for estimating the relative pathogenicity of human genetic variants
Kircher, M., Witten, D. M., Jain, P., O'Roak, B. J., Cooper, G. M., & Shendure, J. (2014) · Nature Genetics · doi:10.1038/ng.2892 · Cited by 6,183
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534 · cited 1×
“…(MAGIC); 17–19 body-weight, height, BMI, and waist-to-hip ratio from the Genetic Investigation of Anthropometric Traits consortium (GIANT); 20,21 and type 2 diabetes from the Diabetes Genetics Replication and Meta-analysis consortium (DIAGRAM) 22 and Exome chip 80K. 23 Additionally,…”
Self-citationSequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Abifadel, M., Varret, M., Rabès, J.-P., Allard, D., Ouguerram, K., Devillers, M., Cruaud, C., Benjannet, S., Wickham, L., Erlich, D., et al. (2003) · Nature Genetics · doi:10.1038/ng1161 · Cited by 2,985
Willer (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Self-citationStatistical Analysis With Missing Data
Lazar, N. A. (2003) · Technometrics · doi:10.1198/tech.2003.s167 · Cited by 2,458
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Self-citationThe MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Self-citationRecent Developments in Mendelian Randomization Studies
Zheng, J., Baird, D., Borges, M.-C., Bowden, J., Hemani, G., Haycock, P., Evans, D. M., & Smith, G. D. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0128-6 · Cited by 1,147
Mendelian randomization for cardiovascular diseases: Principles and applications
Larsson, S. C., Butterworth, A. S., & Burgess, S. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad736 · Cited by 735
“95,104,105 As a further example, cis -MR analyses have been performed to predict the cardiovascular effects of lowering circulating levels of Lp(a).”
Metadata
- Authors
- Schmidt, A. F., Swerdlow, D. I., Holmes, M. V., Patel, R. S., Fairhurst-Hunter, Z., Lyall, D. M., Hartwig, F. P., Horta, B. L., Hyppönen, E., Power, C., Moldovan, M., van Iperen, E., Hovingh, G. K., Demuth, I., Norman, K., Steinhagen-Thiessen, E., Demuth, J., Bertram, L., Liu, T., Coassin, S., Willeit, J., Kiechl, S., Willeit, K., Mason, D., Wright, J., Morris, R., Wanamethee, G., Whincup, P., Ben-Shlomo, Y., McLachlan, S., Price, J. F., Kivimaki, M., Welch, C., Sanchez-Galvez, A., Marques-Vidal, P., Nicolaides, A., Panayiotou, A. G., Onland-Moret, N. C., van der Schouw, Y. T., Matullo, G., Fiorito, G., Guarrera, S., Sacerdote, C., Wareham, N. J., Langenberg, C., Scott, R., Luan, J., Bobak, M., Malyutina, S., Pająk, A., Kubinova, R., Tamosiunas, A., Pikhart, H., Husemoen, L. L. N., Grarup, N., Pedersen, O., Hansen, T., Linneberg, A., Simonsen, K. S., Cooper, J., Humphries, S. E., Brilliant, M., Kitchner, T., Hakonarson, H., Carrell, D. S., McCarty, C. A., Kirchner, H. L., Larson, E. B., Crosslin, D. R., de Andrade, M., Roden, D. M., Denny, J. C., Carty, C., Hancock, S., Attia, J., Holliday, E., O'Donnell, M., Yusuf, S., Chong, M., Pare, G., van der Harst, P., Said, M. A., Eppinga, R. N., Verweij, N., Snieder, H., Christen, T., Mook-Kanamori, D. O., Gustafsson, S., Lind, L., Ingelsson, E., Pazoki, R., Franco, O., Hofman, A., Uitterlinden, A., Dehghan, A., Teumer, A., Baumeister, S., Dörr, M., Lerch, M. M., Völker, U., Völzke, H., Ward, J., Pell, J. P., Smith, D. J., Meade, T., Maitland-van der Zee, A. H., Baranova, E. V., Young, R., Ford, I., Campbell, A., Padmanabhan, S., Bots, M. L., Grobbee, D. E., Froguel, P., Thuillier, D., Balkau, B., Bonnefond, A., Cariou, B., Smart, M., Bao, Y., Kumari, M., Mahajan, A., Ridker, P. M., Chasman, D. I., Reiner, A. P., Lange, L. A., Ritchie, M. D., Asselbergs, F. W., Casas, J.-P., Keating, B. J., Preiss, D., Hingorani, A. D., & Sattar, N.
- Affiliations
- Farr Institute (GB)
- University College London (GB)
- University of Oxford (GB)
- St Bartholomew's Hospital (GB)
- Centre for Human Genetics (GB)
- University of Glasgow (GB)
- Universidade Federal de Pelotas (BR)
- University of South Australia (AU)
- Amsterdam UMC Location University of Amsterdam (NL)
- Charité – Universitätsmedizin Berlin (DE)
- Institute for Integrative and Experimental Genomics (DE)
- Max Planck Institute for Human Development (DE)
- Innsbruck Medical University (AT)
- Bradford Royal Infirmary (GB)
- University of Bristol (GB)
- University of London (GB)
- University of Edinburgh (GB)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Nicosia (CY)
- Cyprus University of Technology (CY)
- Italian institute for Genomic Medicine (IT)
- Azienda Ospedaliero Universitaria San Giovanni Battista (IT)
- University of Cambridge (GB)
- Novosibirsk State Medical University (RU)
- Jagiellonian University (PL)
- Capital Region of Denmark (DK)
- University of Copenhagen (DK)
- Marshfield Clinic Research Foundation (US)
- Children's Hospital of Philadelphia (US)
- Kaiser Permanente Washington Health Research Institute (US)
- Essentia Health (US)
- Geisinger Medical Center (US)
- Vanderbilt University (US)
- George Washington University (US)
- University of Newcastle Australia (AU)
- Population Health Research Institute (CA)
- University Medical Center Groningen (NL)
- Leiden University Medical Center (NL)
- Uppsala University (SE)
- Erasmus MC (NL)
- Universitätsmedizin Greifswald (DE)
- London School of Hygiene & Tropical Medicine (GB)
- Utrecht University (NL)
- Institute of Genetics and Cancer (GB)
- University Medical Center Utrecht (NL)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- University of Essex (GB)
- Brigham and Women's Hospital (US)
- University of Washington (US)
- University of Colorado Anschutz (US)
- Pennsylvania State University (US)
- University of Pennsylvania (US)
- Corresponding author
- Schmidt, Amand F
- ORCID
- Schmidt, Amand F
- Swerdlow, Daniel I
- Holmes, Michael V
- Patel, Riyaz S
- Lyall, Donald M
- Hartwig, Fernando Pires
- Horta, Bernardo Lessa
- Hyppönen, Elina
- Power, Christine
- Moldovan, Max
- Hovingh, G Kees
- Demuth, Ilja
- Norman, Kristina
- Bertram, Lars
- Liu, Tian
- Coassin, Stefan
- Willeit, Johann
- Kiechl, Stefan
- Willeit, Karin
- Mason, Dan
- Wright, John
- Morris, Richard
- Whincup, Peter
- McLachlan, Stela
- Price, Jackie F
- Welch, Catherine
- Marques-Vidal, Pedro
- Nicolaides, Andrew
- Panayiotou, Andrie G
- Matullo, Giuseppe
- Fiorito, Giovanni
- Guarrera, Simonetta
- Sacerdote, Carlotta
- Wareham, Nicholas J
- Langenberg, Claudia
- Luan, Jian'an
- Malyutina, Sofia
- Pająk, Andrzej
- Pikhart, Hynek
- Husemoen, Lise Lotte Nystrup
- Grarup, Niels
- Pedersen, Oluf
- Hansen, Torben
- Linneberg, Allan
- Cooper, Jackie
- Humphries, Steve E
- Brilliant, Murray
- Hakonarson, Hakon
- Carrell, David S
- McCarty, Catherine A
- Kirchner, H Lester
- Larson, Eric B
- Crosslin, David R
- Roden, Dan M
- Denny, Joshua C
- Carty, Cara
- Hancock, Stephen
- Attia, John
- O'Donnell, Martin
- Yusuf, Salim
- Chong, Michael
- Said, M Abdullah
- Verweij, Niek
- Snieder, Harold
- Christen, Tim
- Gustafsson, Stefan
- Lind, Lars
- Ingelsson, Erik
- Pazoki, Raha
- Franco, Oscar
- Dehghan, Abbas
- Teumer, Alexander
- Baumeister, Sebastian
- Dörr, Marcus
- Lerch, Markus M
- Völker, Uwe
- Völzke, Henry
- Ward, Joey
- Pell, Jill P
- Baranova, Ekaterina V
- Young, Robin
- Ford, Ian
- Campbell, Archie
- Padmanabhan, Sandosh
- Bots, Michiel L
- Grobbee, Diederick E
- Froguel, Philippe
- Balkau, Beverley
- Bonnefond, Amélie
- Cariou, Bertrand
- Smart, Melissa
- Bao, Yanchun
- Mahajan, Anubha
- Ridker, Paul M
- Chasman, Daniel I
- Reiner, Alex P
- Ritchie, Marylyn D
- Asselbergs, Folkert W
- Casas, Juan-Pablo
- Keating, Brendan J
- Preiss, David
- Hingorani, Aroon D
- Sattar, Naveed
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 5
- Issue
- 2
- Pages
- 97-105
- ISSN
- 2213-8587 (ISSN-L)
- PMC
- PMC5266795
- OpenAlex
- W2559592043
- Cited by
- 380
- References
- 43
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 29 · 2023: 29 · 2022: 35 · 2021: 49 · 2020: 36 · 2019: 46 · 2018: 64 · 2017: 52
- FWCI
- 60.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- UniSA Research Outputs Repository (University of South Australia) (acceptedVersion, other-oa)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Leicester Research Archive (University of Leicester) (acceptedVersion, other-oa)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- Open Access at Essex (University of Essex) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Leiden Repository (Leiden University) (submittedVersion, cc-by)
- Leiden Repository (Leiden University) (submittedVersion, public-domain)
- IRIS (submittedVersion, public-domain)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, public-domain)
- Ktisis at Cyprus University of Technology (Cyprus University of Technology) (submittedVersion, cc-by)
- MPG.PuRe (Max Planck Society) (submittedVersion, public-domain)
- Explore Bristol Research (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion)
- Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- HAL (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Max Planck Digital Library (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Lithuanian University of Health Sciences (submittedVersion, cc-by)
- Leiden Repository (Leiden University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- SERVAL (Université de Lausanne) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- NOVA (University of Newcastle Australia) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- British Heart Foundation Programme Grant (RG/10/12/28456)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- PCSK9, type 2 diabetes, LDL cholesterol, PCSK9 inhibitors, fasting blood glucose, body weight, waist-to-hip ratio, HbA1c, fasting insulin, statin safety, hyperglycemia, genetic variants, diabetes risk, drug safety assessment, LDL-C lowering therapy, HMG-CoA reductase, body mass index, insulin resistance biomarkers
- MeSH terms
- Proprotein Convertase 9, Blood Glucose, Diabetes Mellitus, Type 2, Humans, Cholesterol, LDL, Genetic Variation, Cohort Studies, Case-Control Studies, Randomized Controlled Trials as Topic, Genetic Predisposition to Disease, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. https://app.cochat.ai/papers/10.1016/s2213-8587(16)30396-5
- The paper
- Schmidt, A. F., Swerdlow, D. I., Holmes, M. V., Patel, R. S., Fairhurst-Hunter, Z., Lyall, D. M., Hartwig, F. P., Horta, B. L., Hyppönen, E., Power, C., Moldovan, M., van Iperen, E., Hovingh, G. K., Demuth, I., Norman, K., Steinhagen-Thiessen, E., Demuth, J., Bertram, L., Liu, T., . . . Sattar, N. (2017). PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(16)30396-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.